[Recurrent gallstone formation after successful lysis].
Stiehl
A
A
Med. Universitätsklinik Heidelberg, Bundesrepublik Deutschland.
D000284:Administration, Oral; D002769:Cholelithiasis / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D012008:Recurrence; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage*
D014580:Ursodeoxycholic Acid
Gallenstein-Rezidivbildung nach erfolgreicher Lyse.